ebomi
Colour theme
Sign in
Insider · CIK 0001329010

Chardonnet Laurent

CIK 0001329010 Name as filed on the most recent filing

Filed as Chardonnet Laurent (18)

47 transaction lines · from 18 filings · filed 2008-11-21 to 2023-05-25 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

47 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-05-23 P, Open-market purchase Prelude Therapeutics IncPRLD 27,500, acquired Open Form 4 filing 0001562180-23-004477
2022-12-08 P, Open-market purchase Prelude Therapeutics IncPRLD 47,600, acquired Open Form 4 filing 0001562180-22-008192
2022-06-01 P, Open-market purchase Prelude Therapeutics IncPRLD 42,300, acquired Open Form 4 filing 0001562180-22-004627
2020-01-31 P, Open-market purchase Axcella Health Inc.AXLA 14,820, acquired Open Form 4 filing 0001633070-20-000004
2020-01-27 P, Open-market purchase Axcella Health Inc.AXLA 1,739, acquired Open Form 4 filing 0001104659-20-007760
2020-01-24 P, Open-market purchase Axcella Health Inc.AXLA 1,540, acquired Open Form 4 filing 0001104659-20-007760
2015-03-30 S, Open-market sale Incyte CorpINCY 3 lines 10,653,985, disposed Open Form 4 filing 0001209191-15-030760
2014-05-12 S, Open-market sale Incyte CorpINCY 111,132, disposed Open Form 4 filing 0001181431-14-019566
2014-05-02 S, Open-market sale Incyte CorpINCY 1,752,700, disposed Open Form 4 filing 0001181431-14-018063
2014-02-13 S, Open-market sale Incyte CorpINCY 6,517,578, disposed Open Form 4 filing 0001181431-14-007431
2013-09-09 S, Open-market sale Incyte CorpINCY 1,366,939, disposed Open Form 4 filing 0001181431-13-048232
2013-09-05 S, Open-market sale Incyte CorpINCY 305,968, disposed Open Form 4 filing 0001181431-13-048232
2012-07-05 S, Open-market sale Incyte CorpINCY 4 lines 896,405, disposed Open Form 4 filing 0001181431-12-040006
2012-07-02 S, Open-market sale Incyte CorpINCY 885,484, disposed Open Form 4 filing 0001181431-12-039533
2012-05-01 S, Open-market sale Incyte CorpINCY 317,255, disposed Open Form 4 filing 0001181431-12-026769
2011-06-21 S, Open-market sale Incyte CorpINCY 14 lines 744,395, disposed Open Form 4 filing 0001181431-11-037985
2011-05-06 S, Open-market sale Incyte CorpINCY 104,456, disposed Open Form 4 filing 0001181431-11-028181
2011-04-08 S, Open-market sale Incyte CorpINCY 6 lines 425,126, disposed Open Form 4 filing 0001181431-11-023221
2010-08-09 S, Open-market sale Incyte CorpINCY 4 lines 219,535, disposed Open Form 4 filing 0001181431-10-041192
2008-11-20 P, Open-market purchase Incyte CorpINCY 2 lines 21,677, acquired Open Form 4 filing 0001181431-08-063425

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer
*, Other
Other

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 8
  • Open-market sale 39
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Chardonnet Laurent, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001329010

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.